In a world obsessed with optimization, microdosing GLP-1 agonists is being hailed as the next frontier in performance biohacking. Originally designed for managing type 2 diabetes and obesity, these drugs—like Ozempic®, Wegovy®, and Mounjaro®—deliver potent metabolic benefits. But now, health-conscious individuals and athletes are rethinking the dosage: instead of pursuing massive weight loss, they’re turning …
Why Look Beyond GLP-1s? Semaglutide and its cousins pack punchy weight-loss results – but at lofty prices, weekly injections, and baggage like nausea or lean-mass loss. If you’re curious about oral, more budget-friendly levers that still target metabolic bottlenecks, the berberine – inositol – resveratrol trio is worth a scientist’s double-take. Learn more about these …